US Stem Cell Inc (USRM)

[mdub]

on the financial front: they will release the 10-Q before May 15 due date.

on the science front: myoheart SDF-1 is better than the original because it helps increase blood flow in the area, but has to start back at phase 1 with it.

used stem cells from fat to increase development of blood flow. has worked very well in patients with lower limb ischemia (common in diabetes). pretty remarkable really. plenty of nasty pictures. this one is a point of care kit, so no need to send away to the lab.